Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DermTech Inc DMTKQ

Healthcare Biotechnology
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma... see more

Recent & Breaking News (OTCPK:DMTKQ)

DermTech Announces New Appointment of Monica Tellado to its Board of Directors

Business Wire July 6, 2021

DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category

Business Wire June 24, 2021

DermTech to Partner with University of Barcelona for Research Study on Atopic Dermatitis and Psoriasis

Business Wire June 22, 2021

DermTech Announces Three New Key Leadership Appointments: Chief Medical Officer, Vice President, Sales and Vice President, Information Technology and Digital Systems

Business Wire June 16, 2021

Humacyte to Provide Investor Update on June 7

GlobeNewswire June 4, 2021

DermTech Announces Three New Scientific Advisory Board Members

Business Wire June 2, 2021

Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal

GlobeNewswire May 26, 2021

DermTech Management to Participate in Upcoming Investor Conferences

Business Wire May 18, 2021

DermTech Reports First Quarter 2021 Financial Results

Business Wire May 13, 2021

DermTech Management to Present at the UBS Global Healthcare Virtual Conference

Business Wire May 11, 2021

DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit

Business Wire May 10, 2021

DermTech Pledges up to $1 Million to Raise Awareness and Support Accessibility of Skin Exams

Business Wire May 3, 2021

DermTech to Announce First Quarter Financial Results on May 13, 2021

Business Wire April 29, 2021

DermTech Introduces PLAplus with Improved Sensitivity for Early Detection of Melanoma

Business Wire April 22, 2021

DermTech Joins Skin Cancer Foundation Corporate Council

Business Wire April 19, 2021

OptumInsight Study Describes Cost Savings of DermTech's Pigmented Lesion Assay in the Management of Melanoma

Business Wire April 15, 2021

DermTech Reports Fourth Quarter and Full Year 2020 Financial Results

Business Wire March 4, 2021

DermTech Abstracts Selected to Present at Society of Investigative Dermatology Virtual Meeting

Business Wire February 22, 2021

DermTech to Announce Fourth Quarter 2020 Financial Results on March 4, 2021

Business Wire February 18, 2021

DermTech Management to Participate in Upcoming Investor Conferences

Business Wire February 17, 2021